NEW YORK (GenomeWeb) – Researchers in the Netherlands have developed a diagnostic test to detect lung cancer by examining tumor RNA absorbed by circulating platelets called thrombocytes.

Published in Cancer Cell earlier today, the study investigated the potential and origin of spliced RNA profiles from tumor-educated platelets, or TEPs, for the noninvasive detection of early- and late-stage non-small cell lung cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.